Results 111 to 120 of about 49,092 (212)

Etiological Spectrum and Outcome of Hyponatremia in Tubercular Meningitis Patients: A Hospital-based, Prospective, Observational Study

open access: yesCHRISMED Journal of Health and Research
Background: Hyponatremia in tuberculous meningitis (TBM) is a commonly observed dyselectrolytemia with morbid outcomes if not addressed promptly. Hyponatremia independently contributes to poorer outcomes in hospitalized patients. Several authors reported
Sruthi Ramindla   +4 more
doaj   +1 more source

Hyponatremia and the Thyroid: Causality or Association?

open access: yes, 2014
Thyroid disorders, particularly hypothyroidism, have historically been implicated in the development of serum hyponatremia. However, in more recent years, this paradigm has been challenged, and it has been suggested that the link between hypothyroidism ...
Betul Hatipoglu, Kevin Pantalone
core   +1 more source

The Real‐World Safety Profile of Haloperidol: A Comprehensive Pharmacovigilance Analysis Using the Large‐Scale FAERS Database

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 10, October 2026.
This first comprehensive FAERS‐based pharmacovigilance analysis of haloperidol over two decades characterized the real‐world safety profile across 9916 reports. Strong signals were found for nervous, psychiatric, and cardiac disorders. Known risks were confirmed and novel signals revealed. Sex‐ and age‐specific vulnerabilities were identified. Findings
Nengping Luo   +3 more
wiley   +1 more source

Hyponatremia in stroke

open access: yes, 2014
Introduction: Hyponatremia is a common electrolyte disorder encountered in patients of neurological disorders which is usually either due to inappropriate secretion of Antidiuretic hormone (SIADH) or cerebral salt wasting syndrome (CSWS).
Sheikh Saleem   +4 more
core   +1 more source

The genetic architecture of epilepsy across molecular mechanisms and clinical heterogeneity

open access: yesEpilepsia Open, Volume 11, Issue 5, Page 1395-1412, October 2026.
Abstract Epilepsy comprises a highly heterogeneous group of neurological disorders unified by a persistent predisposition to recurrent seizures, yet driven by remarkably diverse genetic, molecular, and network‐level mechanisms. Advances in genomic technologies have revealed that epilepsy arises from a multilayered genetic architecture encompassing rare
Mohammad Reza Seyedtaghia   +4 more
wiley   +1 more source

Hyponatremia

open access: yes, 2010
Discussion of the pathophysiology, causes, diagnosis and treatment of ...
Feldman, Harvey
core  

Hyponatremia with an Osmolar Gap, Pseudohyponatremia or Hyper-Osmolar Hyponatremia?

open access: yes
Pseudohyponatremia is frequently misunderstood and often mistaken for other types of hyponatremia. In this study, we present a case of pseudohyponatremia resulting from hypertriglyceridemia.
Bryan M. Tucker   +2 more
core   +1 more source

Dataset Hyponatremia 030718

open access: yes, 2018
Dataset Hyponatremia ...
SALEEM M. AL MAWED (5010014)   +1 more
core   +1 more source

A Seven‐Year Retrospective Study on the Epidemiology of Cutaneous Adverse Drug Reactions in Hospitalized Patients From Southern Iran: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Introduction Cutaneous adverse drug reactions (CADRs) represent a significant clinical challenge, ranging from mild to life‐threatening conditions such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN). This study aims to evaluate the epidemiological and clinical characteristics of CADRs in patients admitted to a tertiary ...
Mohammadreza Keshtkar   +5 more
wiley   +1 more source

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

open access: yesInternational Journal of Cancer, Volume 159, Issue 7, Page 1735-1749, 1 October 2026.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy